Maternal serum adiponectin at 11 to 13 weeks of gestation in the prediction of macrosomia

Prenatal Diagnosis

Volumn 31, Issue 5, 2011, Pages 479-483

  Nanda, Surabhi ^a   Akolekar, Ranjit ^a   Sarquis, Rita ^a,b   Mosconi, Ana Paula ^a,b   Nicolaides, Kypros H ^a,b  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Adiponectin; Biochemical markers; First trimester screening; Macrosomia; Pyramid of prenatal care

Indexed keywords

ADIPONECTIN;

ADULT; ARTICLE; BIRTH WEIGHT; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DELIVERY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; MACROSOMIA; MATERNAL SERUM; NEWBORN; PREGNANCY OUTCOME; PRIORITY JOURNAL; SCREENING TEST;

ADIPONECTIN; ADULT; BIOLOGICAL MARKERS; BIRTH WEIGHT; BODY WEIGHT; CASE-CONTROL STUDIES; FEMALE; FETAL MACROSOMIA; HUMANS; INFANT, NEWBORN; PARITY; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; PRENATAL DIAGNOSIS; PROSPECTIVE STUDIES; ROC CURVE;

EID: 79954584547     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2723     Document Type: Article

References (31)

1. Arita Y, Kihara S, Ouchi N, et al. 1999. Paradoxical decrease of an adipose-specific protein, adiponectin in obesity. Biochem Biophys Res Commun 257: 79-83.
2. Bergmann S, Siekmeier R. 2009. Influence of smoking and body weight on adipokines in middle aged women. Eur J Med Res 14: 21-26.
3. Bo S, Menato G, Gallo ML, et al. 2004. Mild gestational hyperglycemia, the metabolic syndrome and adverse neonatal outcomes. Acta Obstet Gynecol Scand 83: 335-340.
4. Clausen T, Burski TK, Øyen N, Godang K, Bollerslev J, Henriksen T. 2005. Maternal anthropometric and metabolic factors in the first half of pregnancy and risk of neonatal macrosomia in term pregnancies. A prospective study. Eur J Endocrinol 53: 887-894.
5. Ferber A. 2000. Maternal complications of fetal macrosomia. Clin Obstet Gynecol 43: 335-339.
6. Grassi AE, Giuliano MA. 2000. The neonate with macrosomia. Clin Obstet Gynecol 43: 340-348.
7. Hara K, Horikoshi M, Yamauchi T, et al. 2006. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care 29: 1357-1362.
8. Henriksen T. 2008. The macrosomic fetus: a challenge in current obstetrics. Acta Obstet Gynecol Scand 87: 134-145.
9. Hotta K, Funahashi T, Arita Y, et al. 2000. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20: 1595-1599.
10. Kagan KO, Wright D, Baker A, Sahota D, Nicolaides KH. 2008. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin, and pregnancy associated plasma protein-A. Ultrasound Obstet Gynecol 31: 618-624.
11. Lowe LP, Metzger BE, Lowe L, Dyer AR, McDade TW. 2010. Inflammatory mediators and glucose in pregnancy: results from a subset of the hyperglycemia and adverse pregnancy outcome (HAPO) study. J Clin Endocrin Metab 95: 5427-5434.
12. Mazaki-Tovi S, Romero R, Kusanovic JP, et al. 2008. Adiponectin multimers in maternal plasma. J Matern Fetal Neonatal Med 21: 796-815.
13. Meilleur KG, Doumatey A, Huang H, et al. 2010. Circulating adiponectin is associated with obesity and serum lipids in West Africans. J Clin Endocrinol Metab 95: 3517-3521.
14. Mente A, Razak F, Blankenberg S, et al. 2010. Ethnic variation in adiponectin and leptin levels and their association with adiposity and insulin resistance. Diabetes Care 33: 1629-1634.
15. Metzger BE, Lowe LP, Dyer AR, et al.2008. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 358: 1991-2002.
16. Nanda S, Savvidou M, Syngelaki A, Akolekar R, Nicolaides KH. 2011. Prediction of gestational diabetes mellitus from maternal factors and biomarkers at 11-13 weeks. Prenat Diagn 31: 135-141.
17. Nien JK, Mazaki-Tovi S, Romero R, et al. 2007. Plasma adiponectin concentrations in non-pregnant, normal and overweight pregnant women. J Perinat Med 35: 522-531.
18. Ong GK, Hamilton JK, Sermer M, et al. 2007. Maternal serum adiponectin and infant birthweight: the role of adiponectin isoform distribution. Clin Endocrinol (Oxf) 67: 108-114.
19. Paradisi G, Ianniello F, Tomei C, et al. 2010. Longitudinal changes of adiponectin, carbohydrate and lipid metabolism in pregnant women at high risk for gestational diabetes. Gynecol Endocrinol 26: 539-545.
20. Pinar H, Pinar T, Singer DB. 2000. Beta-cell hyperplasia in macrosomic infants and fetuses of nondiabetic mothers. Pediatr Dev Pathol 3: 48-52.
21. Poon LCY, Karagiannis G, Stratieva V, Syngelaki A, Nicolaides KH. 2011. First-trimester prediction of macrosomia. Fetal Diagn Ther. [E-pub ahead of print]. DOI: 10.1159/000318565.
22. Retnakaran R, Hanley AJ, Raif N, Connelly PW, Sermer M, Zinman B. 2004. Hypoadiponectinaemia in South Asian women during pregnancy: evidence of ethnic variation in adiponectin concentration. Diab Med 24: 388-392.
23. Ricart W, López J, Mozas J, et al.2005. Body mass index has a greater impact on pregnancy outcomes than gestational hyperglycaemia. Diabetologia 48: 1736-1742.
24. Robinson HP, Fleming JE. 1975. A critical evaluation of sonar crown rump length measurements. Br J Obstet Gynaecol 182: 702-710.
25. Salvesen DR, Brudenell JM, Proudler AJ, Crook D, Nicolaides KH. 1993. Fetal pancreatic beta-cell function in pregnancies complicated by maternal diabetes mellitus: relationship to fetal acidemia and macrosomia. Am J Obstet Gynecol 168: 1363-1369.
26. Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH. 1998. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Lancet 352: 343-346.
27. Swarbrick MM, Havel PJ. 2008. Physiological, pharmacological, and nutritional regulation of circulating adiponectin concentrations in humans. Metab Syndr Relat Disord 6: 87-102.
28. Waki H, Yamauchi T, Kamon J, et al. 2003. Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem 278: 40352-40363.
29. Wang J, Wang SH, Shang LX, et al. 2010. Relationship of adiponectin and resistin levels in umbilical and maternal serum with fetal macrosomia. J Obstet Gynaecol Res 36: 533-537.
30. Williams MA, Qiu C, Muy-Rivera M, Vadachkoria S, Song T, Luthy DA. 2004. Plasma adiponectin concentrations in early pregnancy and subsequent risk of gestational diabetes mellitus. J Clin Endocrinol Metab 89: 2306-2311.
31. Zweig MH, Campbell G. 1993. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 39: 561-577.